Posts

Showing posts from June, 2018

MODERN CANCER SOLUTIONS TO POST-9/11 RESPONDER CASES

Image
Edited by: Carmen Regallo-Dewitt

Since January of 2015, the American Society of Clinical Oncology (ASCO) and The Society of Immunotherapy of Cancer (SITC) had their first joint conference in Orlando Florida where ASCO president Dr. Bruce E. Johnson publicly stated, “the future of oncology care is through immunotherapy.”  Dr. Jesse Stoff recognized this as the tipping point for the medical community to welcome more cancer treatment options and the integrative philosophy.


Aligning with THE FEALGOOD FOUNDATION (national 9/11 victims advocacy group), Dr. Stoff collaborated with NYC-based cancer diagnostic imaging specialist Dr. Robert Bard to form a dedicated program called 911CancerScan.  This effort conducts a major outreach to seek out first responders and survivors- offering resources and a set of advanced treatment options and services that are covered by the VCF (Victims Compensation Fund) once the patient’s case is certified as a 9/11-related issue.  

Dr. Stoff's career as an inte…